Phil Boyd in

Phil Boyd

Login to view DISC.
Chief Financial Officer at Enterprise Therapeutics Ltd
📍 Oxford, England, United Kingdom

Dr. Phil Boyd is a seasoned Chief Financial Officer with over 20 years of experience leading finance in private and public life science companies. Holding a PhD in Genetics from the University of Leeds, he has guided firms like Enterprise Therapeutics and Syntaxin Ltd through significant growth and acquisition. Colleagues describe him as intelligent, astute, and a pleasure to work with.

Phil maintains a strong connection to academia and industry advancement. His background includes an exchange scheme at Vanderbilt University and roles such as a Visiting Fellow, demonstrating a commitment to fostering collaboration between scientific research and commercial enterprise. He also serves as a Non-Executive Director for UK BioCentre, furthering industry development.

He has chaired the BioIndustry Associations Finance and Tax Advisory Committee, influencing key financial policy discussions within the UK life sciences sector.

Read the full overview →
Experience
11 Years
Current Role
Chief Financial Officer
Job Level
Leadership
Location
Oxford, England, United Kingdom
Personality Overview

How Phil shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Phil cares about

Life Sciences Finance
His career is defined by senior financial roles at biotech and pharmaceutical companies, including Enterprise Therapeutics, Nucleome Therapeutics, and Evotec.
Genomic Innovation
He has publicly shared his excitement for Nucleome Therapeutics' work in decoding the "dark matter of the human genome. "
+4 more topics Login to view topics
Career

Work history

9-2015
Chief Financial Officer
Enterprise Therapeutics Ltd
7-2013
Director
PhiGi Associates Ltd
4-2022 - 7-2024
Chief Financial Officer
Nucleome Therapeutics
2-2017 - 11-2022
Non Executive Director
UK Biocentre
3-2016 - 4-2020
Chief Financial Officer
Caldan Therapeutics
In the press

Media appearances

Leadership Team – Enterprise Therapeutics (Chief Financial Officer Phil Boyd). Featured in Enterprise Therapeutics Ltd.
See now
Education
1985 - 1988
PhD
University of Leeds
1984 - 1985
Exchange scheme
Vanderbilt University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Phil. Free, 10 seconds.